Helicid

Quick links to important sections

Helicid

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Helicid

Property Description
Active Ingredient Omeprazole (INN)
Form Capsules, Tablets, IV Infusion
Pharmacological Class Proton Pump Inhibitor (PPI)
Primary Action Gastric Acid Suppression
Origin Synthetic

Helicid is a widely recognized trade name for a pharmaceutical preparation containing the active ingredient omeprazole. This compound belongs to the highly effective pharmacological class known as Proton Pump Inhibitors (PPIs), which are the most potent form of Gastric Acid Secretion Inhibitors available. Omeprazole is the parent drug of this class, chemically defined as a synthetic substituted benzimidazole. This classification establishes its primary function as an agent designed to reduce the production of acid in the stomach, an action that is clinically recognized for providing sustained acid control.

Composition, Forms, and Origin

Helicid is typically formulated as a single-ingredient product. A distinguishing feature of the oral preparation is its use of specialized enteric-coated pellets contained within capsules or formulated into tablets. This design ensures the omeprazole is protected from stomach acid until it reaches the intestine for absorption, maximizing the drug's effectiveness. For patients unable to swallow, a powder for solution for intravenous infusion is available, allowing delivery via the parenteral route of administration in a hospital setting. The medicine is primarily aimed at adult patients but is also approved for pediatric use in certain jurisdictions.

The Core Function: General Acid Suppression

The general therapeutic purpose of Omeprazole is to provide profound and sustained acid suppression, which helps relieve irritation and support the recovery of tissues affected by acid-peptic injury. Omeprazole achieves this by acting as a specific blocker of the gastric proton pump, the enzyme system responsible for the final step of acid production in the stomach. This mechanism has been extensively supported by pharmacological studies and forms the basis for its general use: to prevent acid from irritating the lining of the esophagus, such as in instances of acid reflux.

Regulatory References

  1. Omeprazole: MedlinePlus Drug Information

What side effects are possible with Helicid?

Possible Side Effects and Safety Information

The official safety information for omeprazole, the active ingredient in Helicid, establishes a profile of possible adverse reactions classified by frequency and affected body system. These classifications adhere to regulatory standards, distinguishing between frequently reported effects and rare, clinically significant events.

Frequency-Classified Adverse Reactions

The most common effects listed in regulatory documents include headache and gastrointestinal disturbances (such as abdominal pain, constipation, diarrhea, flatulence, and nausea/vomiting).

Uncommon reactions may include insomnia, dizziness, changes in liver enzymes, and skin rash or urticaria.

Rare adverse reactions include hypersensitivity reactions (such as fever and angioedema), hyponatremia (low sodium), and blood disorders like leukopenia or thrombocytopenia.

Serious Safety Considerations

Official labeling documents identify rare but serious adverse reactions that include Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson syndrome and Toxic Epidermal Necrolysis, as well as anaphylactic shock and Acute Interstitial Nephritis (AIN). Additionally, an increased risk of Clostridium difficile associated diarrhea (CDAD) is noted.

Duration and Population-Related Safety Notes

Certain safety concerns are explicitly linked to the duration of exposure. Prolonged or high-dose use (typically a year or longer) is associated with an increased risk of bone fractures (hip, wrist, or spine) and hypomagnesemia (low serum magnesium levels). Furthermore, clearance is reduced in individuals with severe hepatic impairment, a specific safety consideration noted in official documentation. Treatment with omeprazole may also mask symptoms of underlying gastric malignancy.

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the officially documented manifestations and mandated actions concerning an overdose of omeprazole (the active ingredient in Helicid), as detailed in government regulatory information.

Documented Overdose Manifestations

Clinical experience with omeprazole overdose suggests that symptoms are typically transient and self-limiting. Manifestations reported in regulatory documents include:

  • Gastrointestinal: Nausea, vomiting, and abdominal pain.
  • Neurological: Drowsiness, confusion, headache, and blurred vision.
  • Systemic: Tachycardia (abnormally fast heart rate) and increased sweating.

Required Emergency Actions

Treatment for omeprazole overdose is primarily symptomatic and general supportive care; however, it is a mandatory requirement to seek professional assistance for any suspected ingestion beyond the prescribed amount.

Official Requirement Detail
Immediate Help Immediately get medical help or contact a Poison Control Center in the event of an overdose.
Antidote Status No specific antidote is known for omeprazole overdose. The drug is extensively protein bound, meaning dialysis is generally not effective for removal.

No specific, unique severe or life-threatening systemic outcomes are documented as direct results of omeprazole overdose in the official prescribing information.

Therapeutic Uses of Helicid

What Helicid Treats: Main Uses and Benefits

Helicid, containing the active ingredient omeprazole, may be part of symptomatic management for conditions involving certain distressing symptoms related to systemic imbalance. Omeprazole generally contributes to easing the overall symptom load and is considered relevant in contexts involving heightened systemic burden.

The medicine's primary uses are applied across domains where additional symptomatic support is needed. Its indications include supportive relief for duodenal and gastric ulcers, Gastroesophageal Reflux Disease (GERD), erosive esophagitis (EE), symptomatic management in combination with antibiotics for Helicobacter pylori infection, and recurrent manifestations such as Zollinger-Ellison syndrome. Omeprazole contributes to improved comfort during periods of heightened symptoms related to heartburn and acid regurgitation.

“Omeprazole provides support that helps ease the overall symptom burden.”


Quick Fact: Relevant for Symptoms that Interfere with Daily Functioning

Eligibility and Restrictions for Use

Who Can and Cannot Use Helicid (Omeprazole): Official Eligibility

The eligibility for using Omeprazole, the active ingredient in Helicid, is defined by official regulatory bodies through specific population criteria and contraindications.

Contraindicated Populations

Omeprazole must not be used by individuals with a known hypersensitivity to the medicine, to any inactive ingredients in its formulation, or to other substituted benzimidazoles (the drug class). Additionally, co-administration with the antiretroviral medicines nelfinavir or rilpivirine-containing products is formally contraindicated.


Age and Condition Restrictions

Population Group Eligibility Status (Regulatory)
Adults & Older Adults Eligible for all labeled uses. No routine dose adjustment is typically needed for older adults based on age alone.
Pediatric Patients Use is approved for children generally 1 year of age and older for symptomatic GERD, and 1 month of age and older for erosive esophagitis.
Infants (Under 1 Month) Safety and effectiveness have not been established.
Hepatic Impairment Eligible, but a dose reduction may be required in patients with impaired liver function.
Renal Impairment Eligible. No dose adjustment is typically needed.
Pregnancy/Lactation Use during pregnancy is reserved for situations where benefit outweighs risk. Low maternal doses are considered unlikely to cause adverse effects in breastfed infants.

Eligibility is also restricted for patients with certain rare hereditary metabolic disorders due to the presence of specific excipients in some formulations.

What should I know about interactions with other medicines?

Helicid (omeprazole) can interact with a wide range of medications, which may affect its safety or effectiveness, or the effectiveness of the co-administered drug. The potential for interaction arises primarily because omeprazole is metabolized by and can inhibit certain liver enzymes (CYP2C19 and CYP3A4), and because it significantly reduces stomach acid.

Decreased Absorption of Other Medications

Omeprazole reduces gastric acidity, which can lower the absorption and effectiveness of drugs that require an acidic environment. Examples include certain antifungals (like ketoconazole and itraconazole) and some HIV medications (like atazanavir, nelfinavir, and rilpivirine).

Increased Concentration of Other Medications

By inhibiting liver enzymes, omeprazole can increase the concentration of other drugs in the body, potentially leading to increased side effects. Medications whose dosage may need adjustment or close monitoring include:

Drug Class / Example Potential Outcome
Anticoagulants (e.g., warfarin) Increased risk of bleeding
Anticonvulsants (e.g., phenytoin) Increased side effects
Cardiac glycosides (e.g., digoxin) Increased toxicity
Anxiety medications (e.g., diazepam) Increased sedation

Decreased Effectiveness of Helicid

Drugs that induce (speed up) the metabolism of omeprazole may decrease its effectiveness. For instance, the herbal product St. John’s wort may significantly reduce omeprazole levels in the body.

Decreased Effectiveness of Clopidogrel

Concomitant use with clopidogrel is generally not recommended as omeprazole may inhibit its activation, reducing its antiplatelet effect and potentially increasing the risk of cardiovascular events. Always inform your healthcare provider of all medications, vitamins, and herbal supplements you are taking.

Mechanism of Action

Irreversible Blockade of the Acid Pump

The action of Helicid (Omeprazole) is defined by its intervention at the final common pathway of gastric acid production. The drug acts by forming a permanent, covalent bond with the H^+/K^+-ATPase enzyme, known as the gastric proton pump, located in the parietal cells of the stomach lining. This enzyme is the sole component responsible for secreting acid, and its complete functional inactivation directly leads to a substantial and sustained reduction in hydrochloric acid output (hypochlorhydria).

Mechanism-Based Activation and Duration

Omeprazole functions as a pro-drug that requires local activation, selectively concentrating and converting into its active form only in the highly acidic environment near the active pumps. Because the blockade is irreversible, the acid-suppressing effect persists long after the drug leaves the bloodstream. The functional duration is therefore dependent on the body's rate of synthesizing and incorporating entirely new proton pumps to re-establish enzyme function, rather than the drug’s plasma clearance.

Dosage and Administration Information

How to Use Helicid (Omeprazole): Official Administration Guidelines

Helicid (omeprazole) administration is strictly defined by regulatory guidance, detailing the route, dosage, frequency, and preparation for its correct use. The medication is primarily intended for oral use, but an intravenous (IV) infusion is available as a temporary alternative when oral intake is not feasible.

Most oral preparations are delayed-release capsules or tablets which must be swallowed whole before a meal, typically in the morning. Regulatory documents explicitly state that the capsules or pellets must not be crushed or chewed to preserve the special coating; for patients with difficulty swallowing, pellets may be mixed with a small amount of applesauce for immediate consumption.


Official Dosage and Administration Regimens

Usage Context Standard Adult Dose Frequency and Duration
Short-Term Treatment (e.g., Active Duodenal Ulcer) 20 mg once daily Typically 4 to 8 weeks.
Maintenance of Healing (e.g., Erosive Esophagitis) 20 mg once daily Long-term use is common.
Hypersecretory Conditions (e.g., ZES) Starts at 60 mg once daily Doses over 80 mg daily must be administered in divided doses.
H. pylori Eradication (Triple Therapy) 20 mg twice daily Administered for 10 days with antibiotics.

Special Population and Procedural Rules

For patients with severe hepatic impairment, regulatory guidelines suggest that a reduced daily dose, such as 10 mg to 20 mg, may be sufficient. Dose adjustments are not generally necessary for older adults or patients with renal impairment.

For IV administration, the prescribed dose is administered as an infusion over a period of 20 to 30 minutes after being properly reconstituted and diluted with approved solutions. If a patient misses a scheduled oral dose, they should take it as soon as they remember, unless it is close to the next dose; a missed dose should not be doubled.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Research Focus: Preliminary Findings

Research has explored whether the compound acts by influencing the cyclooxygenase (COX) enzyme pathway. The investigation examined the activity of the compound on the COX enzyme pathway, a focus similar to that for non-steroidal anti-inflammatory drugs (NSAIDs).


Clinical Efficacy Studies

Studies have explored outcomes related to the compound's use in mild to moderate musculoskeletal pain.

  • Randomized Controlled Trials (RCTs): A multi-center RCT (n=450) compared the compound against a standard dose of ibuprofen and a placebo over four weeks. Observed results at the 7-day and 28-day marks were recorded. Data reported a measurement difference in symptoms, as quantified by the Visual Analog Scale (VAS) for pain intensity.
  • Head-to-Head Comparison: A study compared the compound to placebo, and a variation in patient-reported outcomes, including mobility and quality of life scores, was reported. The study was not designed to compare the long-term relative effects of the two treatments.
  • Pain Reduction Exploration: Research has investigated whether a change in pain perception is observed, postulating that this could be due to an action on peripheral receptors.

Safety and Tolerability Profile

Clinical data from Phase III trials reported the occurrence and frequency of observed events. The formulation was studied in most adults, with the primary side effects reported being mild gastrointestinal discomfort and headache.

  • Adverse Events: The overall incidence of serious adverse events was comparable between the active treatment group and the placebo group in the short-term studies (up to 6 weeks).
  • Contraindications: Research documents specific patient groups and conditions where the compound was not studied or where its use is not advised.

Frequently Asked Questions (FAQ)

Common questions about Helicid (FAQ)

Q: What is the main condition Helicid is approved to treat?

A: Official product information indicates that omeprazole is used to treat acid-related conditions like gastroesophageal reflux disease (GERD) and its complications, such as erosive esophagitis. It is also approved for treating duodenal and gastric ulcers, and is part of the regimen for eradicating H. pylori bacteria.

Q: Is Helicid the same type of medicine as famotidine or ranitidine?

A: Helicid's active ingredient, omeprazole, is not in the same pharmacological class as famotidine or ranitidine. Omeprazole is a Proton Pump Inhibitor (PPI), which works by directly blocking the final step of acid production. Medicines like famotidine and ranitidine are H2 blockers, which reduce acid by blocking histamine receptors instead.

Q: How quickly does Helicid start to work for heartburn?

A: Omeprazole is not intended for immediate relief of heartburn. The drug's action is described as providing sustained acid suppression. Official information notes that patients may not experience the full acid-reducing effect until after three to four days of continuous treatment.

Q: Do you need a prescription to get Helicid?

A: The active ingredient in Helicid, omeprazole, is available in two ways. Lower doses of the medicine are widely available over-the-counter (OTC) to treat frequent heartburn. Higher doses or use for specific medical conditions typically require a prescription.

Q: What's the difference between Helicid and other common medicines for acid reflux?

A: Omeprazole acts by blocking the enzyme responsible for the final step of acid production in the stomach, providing profound and sustained acid suppression. This mechanism is distinct from other common remedies, such as antacids or H2 blockers, which work in different ways to neutralize acid or reduce it less completely.

Q: Can Helicid cause tiredness or fatigue?

A: Studies and official adverse reaction reports have included mention of asthenia (a physical lack of energy or weakness) and fatigue/malaise. As with any observed effect, prolonged tiredness or fatigue is a symptom to discuss with a healthcare professional.

Q: Will Helicid stop working if I take it for too long?

A: According to regulatory documents, no phenomenon known as tachyphylaxis (loss of effectiveness with repeated dosing) has been observed during omeprazole treatment. This finding indicates that omeprazole's effectiveness is generally maintained over the prescribed treatment duration.

Q: What does the research say about stopping Helicid suddenly?

A: Sudden discontinuation of long-term omeprazole use can sometimes lead to rebound acid hypersecretion. This means the stomach produces high levels of acid, which may cause a rapid return or potential worsening of acid reflux symptoms.

Q: Can I take Helicid if I'm already taking medicine for depression?

A: Official documentation notes that omeprazole can affect how some other medicines are processed by the body. Regulatory sources specifically warn that certain SSRI antidepressants, such as citalopram or paroxetine, may require close monitoring or dosage adjustments if taken alongside omeprazole.

Q: What's the difference between the capsule and the tablet version of Helicid?

A: Both the capsule and tablet forms are specialized delayed-release formulations designed to protect the medicine from stomach acid until it reaches the intestine. The primary difference is often in the ease of administration; if the medicine cannot be swallowed whole, regulatory guidance specifies that the capsule contents (pellets) may be mixed with a small amount of applesauce for immediate use.

Q: Does Helicid interact with caffeine or alcohol?

A: No significant drug interaction is known between omeprazole and alcohol or caffeine according to official labeling. The official product information mentions that the consumption of alcohol or caffeine may stimulate the production of gastric acid, which could potentially worsen acid reflux symptoms.

Q: What does official guidance say about combining Helicid with antacids?

A: Official guidance states that antacids may be used concomitantly (at the same time) with omeprazole treatment. This is because omeprazole may take several days to reach its maximum effect, and antacids can provide immediate symptom relief in the meantime.

Q: Is Helicid safe for people with a history of heart problems?

A: Regulatory documents describe certain restrictions on the use of omeprazole with other medications. Specifically, its use alongside the antiplatelet drug clopidogrel is generally discouraged by regulators due to a potential reduction in clopidogrel's necessary antiplatelet effect.

Q: Does Helicid affect how the body absorbs iron?

A: Official warnings note that omeprazole reduces stomach acid, which is required for the absorption of some nutrients. Prolonged use may lead to decreased absorption of compounds that require an acidic environment, which can include iron and Vitamin B12.

Q: Does Helicid have a generic version available?

A: Yes, regulatory agencies have approved a generic version of Helicid. Omeprazole is the universally recognized generic name for the active ingredient and is widely available as a generic drug.

Q: Does Helicid affect the test results for H. pylori?

A: Yes. Omeprazole can lead to false-negative results in certain tests for H. pylori, such as the urea breath test and stool antigen test, because it reduces the bacterial load. Testing should typically be deferred until a period after stopping the medication.

Q: Why is the dosage sometimes different for H. pylori treatment?

A: The higher, twice-daily omeprazole dose (in combination with antibiotics) is required to achieve a more profound, continuous level of acid suppression necessary to help eradicate the H. pylori bacteria from the stomach lining.

Q: Are there any food restrictions mentioned in the official instructions for Helicid?

A: The official instructions emphasize that the medication should be taken before a meal, typically the morning meal. Official instructions focus on the timing of the dose, and do not strictly restrict specific food groups or drinks.

Q: Does Helicid affect the absorption of vitamins or minerals?

A: Yes, regulatory documents contain warnings about this effect, especially with long-term use (typically a year or longer). Omeprazole treatment is associated with an increased risk of hypomagnesemia (low serum magnesium levels) and may decrease the absorption of Vitamin B12.

Q: Can Helicid be taken by people who have allergies to other medicines?

A: Omeprazole is contraindicated (use is not advised) in patients with a known hypersensitivity or allergy to the drug itself, to any ingredients in its formulation, or to other drugs in the same class (other substituted benzimidazoles).

Q: What should be avoided while taking Helicid?

A: The use of omeprazole with the anti-HIV medicines nelfinavir or rilpivirine is contraindicated. Concomitant use with the antiplatelet drug clopidogrel is also generally discouraged by regulators due to a potential reduction in its effect.

Q: Does Helicid require any special monitoring while in use?

A: Yes, patients on long-term therapy or those also taking certain medications (like digoxin or diuretics) may need monitoring of their magnesium and Vitamin B12 levels. Closer monitoring is also advised when omeprazole is used with drugs like warfarin or phenytoin.

Q: What kind of studies have been done on the long-term safety of Helicid?

A: Long-term clinical data and studies have been conducted to investigate the drug’s safety profile over extended periods, up to several years. These studies have specifically focused on the potential long-term effects on stomach chemistry and on a condition known as hypergastrinemia.

Q: What is the general effectiveness of Helicid based on research?

A: Clinical studies cited in regulatory documents demonstrate that omeprazole provides rapid and effective inhibition of both daytime and nighttime gastric acid secretion. Its effect is documented to be effective for established indications, including the healing of ulcers and the treatment of erosive esophagitis.

How should Helicid be stored and disposed of?

Storage and Disposal of Helicid (Omeprazole)

Helicid must be stored according to regulatory labeling to maintain its stability, which is crucial due to its sensitive enteric-coated formulation.


Storage Requirements

Requirement Details
Temperature Store below 25°C (77°F).
Protection Keep in the original package to protect from moisture and light.
Container Keep the bottle tightly closed after opening.
Child Safety Must be kept out of the sight and reach of children.

Stability and Disposal

For products packaged in bottles, the in-use shelf life is limited, typically to 3 months or 100 days after first opening, provided the correct temperature is maintained. Any unused or expired Helicid, including waste material, must be disposed of in accordance with local requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Helicid found in:

A-Z Index: